Boardroom Alpha Research

SPACs

SPAC Market Review – May 2022

Inflation, rising interest rates, and reduced corporate earnings across the board have led to persistent market gyrations which prove its too early for bottom fishing. The stampede out of deSPACs now makes it ‘deal-or-die’ time for those without targets.

Automotive Tech in Focus

Two DAs today in auto tech, one would represent China’s biggest U.S. listing since Didi. WeWork fires its CFO. And the rest of the day’s news in SPACs.

MSP Recovery Sinks

MSP Recovery (MSPR) sinks, falling 53% on its debut. Biote gets approval. Lots of extension votes ahead. And the rest of the day’s news in SPACs.

MSP Recovery Debuts Tomorrow

Medicare and Medicaid secondary payer reimbursement recovery specialist MSP Recovery (MSPR) begins trading tomorrow. Extension for TINV/Grindr. And the rest of the day’s news in SPACs.

Comera Life Sciences Debuts in the Red

Comera Life Sciences (CMRA), the maker of self-injectible biologics, deSPAC’d today, closing down 9%. An updated look at deSPAC count and redemption rates. And the rest of the day’s news in SPACs.

SPAC Deals on a Daily Double

Another 2 SPAC DAs today, offset by some liquidations. And the rest of the day’s news in SPACs.

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.